We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated multiple routes that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might take to develop high-level ...
In a recent study posted to the bioRxiv* preprint server, researchers test three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals authorized for emergency use by the United ...
BOSTON--(BUSINESS WIRE)--DeepCure, a leader in discovering novel therapeutics powered by AI and automation, announced today that its Inspired Chemistry™ platform had achieved a breakthrough in ...
Background and Goal: SARS-CoV-2, the virus responsible for the COVID-19 pandemic, remains in circulation. The focus has now shifted to testing and treating ...
The body of research on nirmatrelvir-ritonavir demonstrates a plethora of benefits in the treatment of COVID-19, and authors of a recent study identified more advantages to administering the treatment ...
Please provide your email address to receive an email when new articles are posted on . There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback